Found and Noom compete in the medical weight loss space but with meaningfully different approaches. Found is built around clinical assessment with a broad medication formulary and lighter behavioral coaching. Noom is built around behavioral psychology with optional medication access via Noom Med. The two platforms attract different patients — Found patients usually want medication-driven weight loss with strong clinical assessment, while Noom patients usually want behavioral support with optional medication. This found vs noom comparison breaks down 2026 pricing, the structural differences in approach, and which platform fits which patient profiles. The summary: Found for medical-first weight loss with broader formulary; Noom for behavioral-first weight loss with optional medication add-on.
Found vs Noom — pricing in 2026
Found pricing:
- Standard monthly subscription: $99-129/month
- Annual prepay: reduces per-month cost
- Medications separate (varies from $10-30/month for generics to $1,000+/month for branded GLP-1)
- Optional one-on-one coaching at higher tiers
Noom pricing:
- Standard Noom app: $70/month or $209/year
- Noom Med add-on: ~$149/month additional ($219/month bundled with standard Noom)
- Medications separate
The standard Noom app is cheaper than Found’s program. Noom Med + standard Noom bundled is more expensive than Found. Total cost comparison depends heavily on which products are bundled and what medication is prescribed. See our individual Found review and Noom Med review.
Behavioral content — Noom’s clear strength
Noom’s core asset is its behavioral content. The cognitive-behavioral framing of food psychology, the calorie-density-based food categorization system, the daily lessons, and the structured behavior change content are well-developed. Noom has academic partnerships and published research backing the behavioral approach.
Found’s behavioral content is lighter. The platform offers app-based educational content covering nutrition, exercise, sleep, and emotional health, but it’s not the platform’s centerpiece. For patients who want or need substantial behavioral support, Noom’s content is more developed.
Clinical depth and medication formulary — Found’s clear strength
Found’s clinical assessment is more comprehensive than Noom Med’s. The Found intake covers metabolic markers, hormonal factors, behavioral history, prior weight loss attempts, and contraindications in greater depth, with the assessment data informing medication selection from a broader formulary.
Found’s medication formulary is broader:
- GLP-1 medications including Wegovy and Zepbound
- Metformin off-label for insulin resistance
- Bupropion (Wellbutrin) off-label, especially with comorbid depression
- Naltrexone, often combined with bupropion (Contrave)
- Topiramate off-label, often combined with phentermine (Qsymia)
- Other older weight loss medications
Noom Med’s formulary is narrower, primarily GLP-1 medications. For patients with insulin resistance, mild obesity, or budget constraints where non-GLP-1 medications would fit better, Found’s broader formulary is meaningful.
The “behavioral first” vs “medical first” question
The fundamental question between Found and Noom is whether you want behavioral support as the primary intervention with medication as a tool, or medical management as the primary intervention with behavioral support layered in.
Noom’s approach prioritizes behavioral change. The Noom app is the centerpiece; Noom Med is added when patients want medication. Patients who lose weight on the standard app alone don’t need Noom Med at all. The framing is psychology-first.
Found’s approach prioritizes medical management. The clinical assessment drives the program, medication selection is matched to the patient’s profile, and behavioral content supports the medical intervention. The framing is clinical-first. Both approaches are legitimate; they fit different patients.
Engagement patterns and outcomes
Noom’s standard app produces high engagement during the first 30-90 days followed by significant abandonment. Outcomes are highly correlated with continued engagement — committed users see real weight loss; users who stop engaging within 90 days don’t see meaningful results.
Found’s outcomes track more with medication adherence and clinical engagement. Patients on GLP-1 medications who engage with the platform for monthly check-ins typically lose 10-15% of body weight over 12-18 months. Patients on older weight loss medications see smaller but real outcomes (5-10% weight loss is typical).
Specific use cases — when each platform wins
Choose Found if: Your primary need is medical weight loss with strong clinical assessment. You want broader medication options beyond GLP-1s. You have insulin resistance, budget constraints, or other factors making non-GLP-1 medications appropriate. You don’t need or want intensive behavioral coaching.
Choose Noom (standard app) if: You want behavioral-first weight loss support without medication. You’re self-directed and will engage with daily app content. You’ll potentially add Noom Med later if needed.
Choose Noom + Noom Med if: You’re an existing Noom user who wants to add GLP-1 medication. You value the integration of behavioral content with medication. You want monthly flexibility.
Choose neither if: You want intensive structured coaching. Calibrate‘s 12-month program with weekly coaching sessions provides more intensive support than either Found or Noom.
How both compare to Calibrate, Hims, and Ro
Compared to Calibrate, both Found and Noom are more flexible (monthly vs 12-month) but have lighter coaching. Calibrate’s intensive weekly one-on-one coaching is more impactful than either Found’s lighter coaching or Noom’s app-based content for patients who need accountability.
Compared to Hims and Ro weight loss programs, both Found and Noom offer more clinical and behavioral structure. Hims and Ro deliver primarily medication access with minimal wraparound; Found and Noom add genuine clinical assessment (Found) or behavioral content (Noom). See our Calibrate vs Found and Noom vs Calibrate comparisons.
Frequently Asked Questions
Is Noom or Found cheaper?
The standard Noom app is cheaper than Found ($70 vs $99-129/month). Noom + Noom Med bundled is more expensive than Found. Total cost depends on which Noom products are used.
Which has better behavioral content?
Noom. The behavioral psychology framing, daily lessons, and food categorization system are more developed than Found’s behavioral content.
Which has better medication options?
Found. Found’s medication formulary includes GLP-1s, metformin, bupropion, naltrexone, topiramate, and other older weight loss drugs. Noom Med focuses primarily on GLP-1 medications.
Can I use the standard Noom app with a different medical platform?
Yes. Some patients use the standard Noom app for behavioral content alongside Found, Calibrate, or another medical weight loss platform. There’s no exclusivity.
Which produces better outcomes?
Outcomes depend heavily on engagement and medication choice. Noom’s standard app produces meaningful weight loss for committed users. Found’s medical pathway produces stronger outcomes for patients on GLP-1s with adherence.
The bottom line on Found vs Noom
Found and Noom serve different positioning in weight loss. Found is medical-first with broader medication formulary and stronger clinical assessment but lighter behavioral coaching. Noom is behavioral-first with stronger app content and optional medication via Noom Med. The right choice depends on whether you want medication-driven weight loss with clinical structure (Found) or behavioral-driven weight loss with optional medication (Noom). Some patients combine the standard Noom app for behavioral content with Found or another medical platform for clinical management — this can be more cost-effective than Noom + Noom Med bundled.